Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 1486 AL 1500

Reducing cognitive-motor declines associated with bilateral subthalamic deep brain stimulation through computational modelling in a Parkinson's disease patient

Alberts JL, Hallahan K, Thota A, Noecker AM, Vitek JL, McIntyre CC.

J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1170-2. doi: 10.1136/jnnp.2008.160093. Epub 2010 Aug 27.

[Sonography of the parenchyma in Parkinson's disease]

Hagenah J, Seidel G.

Nervenarzt. 2010 Oct;81(10):1189-95. doi: 10.1007/s00115-010-3025-5.

Levetiracetam for levodopa-induced dyskinesia in Parkinson's disease: a randomized, double-blind, placebo-controlled trial

Wolz M, Löhle M, Strecker K, Schwanebeck U, Schneider C, Reichmann H, Grählert X, Schwarz J, Storch A.

J Neural Transm (Vienna). 2010 Nov;117(11):1279-86. doi: 10.1007/s00702-010-0472-x. Epub 2010 Aug 29.

HIV, HAART, and Parkinson's disease: co-incidence or pathogenetic link?

Tisch S, Brew BJ.

Mov Disord. 2010 Oct 15;25(13):2257-8; author reply 2257. doi: 10.1002/mds.23277.

Recognition by familiarity is preserved in Parkinson's without dementia and Lewy-Body disease

Algarabel S, Rodríguez LA, Escudero J, Fuentes M, Peset V, Pitarque A, Cómbita LM, Mazón JF.

Neuropsychology. 2010 Sep;24(5):599-607. doi: 10.1037/a0019221.

Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases

Fantini J, Yahi N.

Expert Rev Mol Med. 2010 Sep 1;12:e27. doi: 10.1017/S1462399410001602.

Biomarkers in Parkinson's disease

Morgan JC, Mehta SH, Sethi KD.

Curr Neurol Neurosci Rep. 2010 Nov;10(6):423-30. doi: 10.1007/s11910-010-0144-0.

Metabolic activity of the subthalamic nucleus in a primate model of L-dopa-unresponsive parkinsonism

Fernagut PO, Barraud Q, Bezard E, Ghorayeb I, Tison F.

Neurol Res. 2010 Dec;32(10):1050-3. doi: 10.1179/016164110X12807570509934. Epub 2010 Aug 31.

Target-specific PET probes for neurodegenerative disorders related to dementia

Kadir A, Nordberg A.

J Nucl Med. 2010 Sep;51(9):1418-30. doi: 10.2967/jnumed.110.077164.

Parkin directly modulates 26S proteasome activity

Um JW, Im E, Lee HJ, Min B, Yoo L, Yoo J, Lübbert H, Stichel-Gunkel C, Cho HS, Yoon JB, Chung KC.

J Neurosci. 2010 Sep 1;30(35):11805-14. doi: 10.1523/JNEUROSCI.2862-09.2010.

Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease

Chung KA, Lobb BM, Nutt JG, Horak FB.

Neurology. 2010 Oct 5;75(14):1263-9. doi: 10.1212/WNL.0b013e3181f6128c. Epub 2010 Sep 1.

Restoration of segregated, physiological neuronal connectivity by desynchronizing stimulation

Hauptmann C, Tass PA.

J Neural Eng. 2010 Oct;7(5):056008. doi: 10.1088/1741-2560/7/5/056008. Epub 2010 Sep 1.

Gene-environment interactions in Parkinson's disease: the importance of animal modeling

Horowitz MP, Greenamyre JT.

Clin Pharmacol Ther. 2010 Oct;88(4):467-74. doi: 10.1038/clpt.2010.138. Epub 2010 Sep 1.

[The effect of Stalevo-dosing on quality of life of Parkinsonian patients with wearing-off]

Bokor M, Szentesi A.

Ideggyogy Sz. 2010 Jul 30;63(7-8):247-51.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias